Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma

Thorax

Volumn 52, Issue 11, 1997, Pages 940-945

  Sousa, A R ^a   Pfister, R ^b   Christie, P E ^b   Lane, S J ^a   Nasser, S M ^a   Schmitz Schumann, M ^b   Lee, T H ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b Hochgebirgsklinik   (Switzerland)

Author keywords

Aspirin sensitive asthma; Cyclo oxygenase; Epithelium; Mast cells

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2;

ADULT; ARTICLE; ASTHMA; BRONCHUS MUCOSA; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EOSINOPHIL; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MALE; MAST CELL; PRIORITY JOURNAL;

EID: 0030781483     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.11.940     Document Type: Article

References (27)

1. Hamberg M, Svensson J, Samuelsson B. Novel transformation of arachidonic acid in human platelets. Proc Natl Acad Sci USA 1974;71:3400-4.
2. Thiemermann C. Biosynthesis and interaction of endothelium-derived vasoactive mediators. Eicosanoids 1991;4: 187-202.
3. Xie WL, Chipman JG, Robertson DL, Erikson RL, Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 1991;88:2692-6.
4. O'Banion MK, Winn VD, Young DA. cDNA cloning and functional activity of glucocorticoid-regulated inflammatory cyclo-oxygenase. Proc Natl Acad Sci USA 1992;89:4888-92.
5. Maier JA, HLA R, Maciag T. Cyclo-oxygenase is an immediate early gene induced by interleukin-1 in human endothelial cells. J Biol Chem 1990;265:10805-8.
6. Lee SH, Soyoola E, Chanmugam P, Hart S, Sun W, Zhong H, et al. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem 1992;267:25934-8.
7. Mitchell JA, Akarasereenont P, Thiemermann T, Flower RJ, Vane JR. Selectivity of non-steroid antiinflammatory drugs as inhibitors of constitutive and iducible cyclooxygenase. Proc Natl Acad Sci USA 1993;90:11693-7.
8. Samter M, Biers RF. Intolerance to aspirin: clinical studies and consideration of its pathogenesis. Ann Intern Med 1968;6:975-83.
9. 1 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 1991;143: 1025-9.
10. 4 after lysine-aspirin inhalation in asthmatic subjects. Am Rev Respir Dis 1992;146:1531-4
11. Ferreri NR, Howland WC, Stevenson AD, Spiegelberg ML. Release of leukotrienes, prostaglandins and histamine into nasal secretions of aspirin-sensitive asthmatics during reactions to aspirin. Am Rev Respir Dis 1988;137:847-54.
12. Ortolani C, Mirone C, Fontana A, Folco GC, Miadonna A, Montalbetti N, et al. Study of mediators of anaphylaxis in nasal wash fluids after aspirin and sodium meta-bisulphite nasal provocation in intolerant rhinitic patients. Ann Allergy 1987;59:106-12.
13. Sladek K, Dworski R, Soja J, Sheller JR, Nizankowowska E, Oates JA, et al. Eicosanoids in bronchoalveolar lavage fluid of aspirin-tolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med 1994;149:940-6.
14. Nasser SMS, Pfister R, Christie PE, Sousa AR, Barker J, Schmitz-Schumann M, et al. Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects. Am J Respir Crit Care Med 1996;153:90-6.
15. Picado C, Ramis I, Rosello J, Prat J, Bulbena O, Plaza V, et al. Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. Am Rev Respir Dis 1992;145:65-9.
16. Christie P, Smith CM, Lee TH. The potent and selective sulfidopeptide leukotriene antagonist, SK&F104353, inhibits aspirin-induced asthma. Am Rev Respir Dis 1991; 144:957-8.
17. SladeK K, Szczeklik A. A cysteinal leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. Eur Respir J 1993;6:391-9.
18. Sousa AR, Poston RN, Lane SJ, Nakhosteen JA, Lee TH. Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids. Am Rev Respir Dis 1993;147:1557-61.
19. Vane JR. Pharmacology: towards a better aspirin. Nature 1994;367:215-6.
20. Moncada S, Gryglewski R, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxidase to an unstable substance that inhibits platelet aggregation. Nature 1976;263:663-5.
21. Whittle BJR, Higgs GA, Eakins KE, Moncada S, Vane JR. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature 1980; 284:271-3.
22. Mitchell JA, Swierkosz TA, Warner TD, Gross SS, Thiemermann C, Vane JR. Regulation of prostacyclin synthesis by endogenous nitric oxide in response to bacterial lipopolysaccharide. Br J Pharmacol 1993;109:4P
23. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR. TIS10, a phorbol ester tumor promoter-inducible mRNA from swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclo-oxygenase homologue. J Biol Chem 1991;266:12866-72.
24. Meade EA, Smith W, De Witt DL. Differential inhibition of prostaglandin endoperoxidase synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993;268:66610-4.
25. Chafee FH, Settipane GA. Aspirin intolerance. Frequency in an allergic population. J Allergy Clin Immunol 1974;53: 193-9.
26. McDonald JR, Mathison DA, Stevenson DD. Aspirin intolerance in asthma: detection by oral challenge. J Allergy Clin Immunol 1972;50:198-207.
27. Andri L, Senna G, Betteli C, Givanni S, Scaricabozzi I, Mezzelani P, Andri G. Tolerability of nimesulide in aspirin-sensitive patients. Ann Allergy 1994;72:29-32.